MedTrace Logo

Study on Effective Mydriasis in Premature Infants

NCT01054027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-01-22

No results posted yet for this study

Summary

The purpose of this study is to compare the dilating effect of 0, 1, 2 or 3 drops of mydriatic (pupil dilating) in premature infants undergoing routine retinal (eye) screening exams for Retinopathy of Prematurity (ROP).

Conditions

  • Retinopathy of Prematurity (ROP)

Interventions

DRUG

1% phenylephrine and 0.2% cyclopentolate

given as drops, prior to eye exam

Sponsors & Collaborators

  • Georgetown University

    lead OTHER

Principal Investigators

  • Monisha Bahri, MD · Georgetown University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-11-30
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054027 on ClinicalTrials.gov